CAMBRIDGE, UK 09 September 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced a collaboration with leading, global high-performance analog technology company, Analog Devices, Inc. The companies will work together on the advancement and commercial scale-up of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips and accelerate the development of Evonetix’s first product, a DNA desktop writer.
Evonetix’s novel silicon chip controls the…
TTP will provide entrepreneurs with mentoring and tech consultancy, to accelerate product development and commercialisation
Agreement underlines TTP’s commitment to sharing knowledge and experience with innovative start-ups
TTP to deliver virtual seminar on 17 September as part of Start Codon and Cancer Research UK’s Entrepreneurial Training Scheme
Cambridge, UK, 03 September 2020: TTP plc (TTP), a leading independent technology and product development company, has today announced a new partnership with Start Codon, the life science and healthcare business accelerator. The collaboration…
Executive search consultancy, Horton International UK, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.
With a background in manufacturing/quality and development for the vaccine industry, Mark’s expertise has informed his career in executive search for the pharmaceutical, life sciences and healthcare industries, from board level to middle management. Most recently a Partner with a global Life Sciences recruitment business, Mark has spent years focused upon building high-performance leadership and technical teams for fast growing…
AMSBIO announce new additions and certifications for their market-leading range of clinical grade, chemically defined cryopreservation excipient solutions - STEM-CELLBANKER® and HSC-BANKER®.STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent. It was developed for customers who prefer not to use DMSO-containing cryopreservation solution due to the intended application of the samples. STEM-CELLBANKER® DMSO Free GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP…
Cambridge, UK, 01 September 2020: Mursla, a liquid biopsy company, has raised £410K from the UK Government’s Future Fund and existing investors. In addition, the organisation has secured a £40K COVID-19 grant from the Cambridgeshire Capital Grant Scheme.The funding will enable Mursla to finalise its work on its novel exosome-based liquid biopsy platform, ExoPhenoTM, with the aim of demonstrating how the platform can detect cancer signatures in plasma from solid tumours via exosomes.Exosomes are heterogeneous vesicles naturally released by all cells during their lives, especially…
Free COVID-19 risk assessment services are being offered by Bishop Simon. Bishop Simon is a Health, Safety and Biosafety Consultancy. Our Chartered Health and Safety Consultants have served, many scientific research organisations including the Medical Research Council and PSI (CRO). If you would like to tap into or expertise to carry out your COVID-19 risk assessment, review your current COVID-19 risk assessment or inspect your COVID measures then please contact us.
AMSBIO announce a new service designed to provide high-content cytometry data on cells and tissues enabling the automated analysis of fluorescent biomarkers on living cells or long-term stored biobanked cells and tissues.Leveraging the innovative ChipCytometry platform, AMSBIO is able to offer a complete workflow solution (products and services) for high-content cytometry on cells and tissues, from sample preparation and biobanking to biomarker analysis and data mining.The ChipCytometry platform operates by immobilizing cells in microfluidic chips, which are later stained…
The world's focus on healthcare and leadership has never been greater. COVID-19 has led us to place higher value on our health, and question what makes a good leader, in times of crisis and in securing our future.
The Life Sciences industry is somewhat unique, in that it has the power to influence both.
For those working in it, it is a challenging industry with high expectations. To manage a growing ageing population and continuously evolving healthcare needs, the life sciences industry needs innovative, high performing, happy and healthy leaders.
These leaders will be at the forefront…